- Investing Ideas
- /
- U.S. Biotech Breakthroughs
U.S. Biotech Breakthroughs
Results
53
1 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
53 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALNY | US$254.15 | -0.2% | 40.8% | US$32.7b | US$298.77 | PS15.6x | E70.3% | n/a | ||
TGTX | US$31.65 | -6.6% | 89.6% | US$4.5b | US$38.67 | PS17.2x | E57.0% | n/a | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
ARDX | US$5.32 | -4.7% | -2.9% | US$1.2b | US$10.78 | PS5x | E69.6% | n/a | ||
BPMC | US$94.47 | -2.1% | 10.9% | US$6.1b | US$125.58 | PS13.8x | E68.6% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
URGN | US$11.44 | -8.2% | -28.2% | US$508.1m | US$39.93 | PS5.4x | E67.1% | n/a | ||
RNXT | US$1.41 | 18.5% | 77.1% | US$32.9m | US$5.50 | PB4.8x | E69.4% | n/a | ||
TNYA | US$3.66 | 7.0% | 74.3% | US$283.6m | US$18.75 | PB2.6x | E61.5% | n/a | ||
ALDX | US$5.37 | 8.3% | 74.4% | US$315.0m | US$10.00 | PB3.8x | E71.6% | n/a | ||
ABEO | US$6.01 | 0% | 27.3% | US$260.0m | US$16.75 | PB5.7x | E61.8% | n/a | ||
MGTX | US$6.15 | -2.1% | 28.9% | US$489.2m | US$23.25 | PS34.5x | E7.1% | n/a | ||
MDGL | US$306.55 | -3.7% | 34.8% | US$6.8b | US$373.00 | PS87x | E73.1% | n/a | ||
SLNO | US$47.17 | -6.9% | 22.3% | US$2.0b | US$74.25 | PB7.7x | E67.3% | n/a | ||
SWTX | US$39.75 | -6.1% | 15.0% | US$3.1b | US$67.33 | PS21.8x | E70.0% | n/a | ||
CAPR | US$14.24 | 11.9% | 242.3% | US$676.1m | US$41.29 | PS27.9x | E67.6% | n/a | ||
SPRY | US$12.27 | -14.9% | 130.6% | US$1.3b | US$26.50 | PS464.4x | E70.7% | n/a | ||
ACIU | US$3.12 | -2.5% | -13.6% | US$310.7m | US$10.20 | PS6.7x | E54.7% | n/a | ||
ATYR | US$3.17 | -4.8% | 162.0% | US$276.2m | US$21.29 | PS1132.3x | E62.5% | n/a | ||
ARQT | US$12.77 | 1.3% | 436.6% | US$1.5b | US$19.00 | PS10.8x | E72.4% | n/a | ||
PGEN | US$0.75 | -6.8% | -38.5% | US$228.8m | US$6.00 | PS55.4x | E69.8% | n/a | ||
IVVD | US$0.58 | -8.2% | -65.0% | US$71.8m | US$6.51 | PS6x | E71.9% | n/a | ||
XOMA | US$29.35 | -7.5% | 83.6% | US$347.5m | US$89.00 | PS16x | E77.9% | n/a |